Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 1:06 pm Purchase | 13G | TELA Bio Inc. TELA | LYTTON LAURENCE W | 2,452,257 9.900% | 1,112,205 (+83.00%) | View |
| 2024-10-29 5:12 pm Purchase | 13G | TELA Bio Inc. TELA | Stonepine Capital Management LLC | 2,831,839 7.700% | 2,831,839 (New Position) | View |
| 2024-10-28 4:06 pm Unchanged | 13G | TELA Bio Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 4,110,709 10.440% | 0 (Unchanged) | View |
| 2024-10-25 4:24 pm Sale | 13D | TELA Bio Inc. TELA | ORBIMED ADVISORS LLC | 1,182,717 4.800% | -941,550 (-44.32%) | View |
| 2024-10-01 5:35 pm Sale | 13D | TELA Bio Inc. TELA | ORBIMED ADVISORS LLC | 2,124,267 8.600% | -313,700 (-12.87%) | View |
| 2024-07-22 3:20 pm Purchase | 13G | TELA Bio Inc. TELA | LYTTON LAURENCE W | 1,340,052 5.400% | 1,340,052 (New Position) | View |
| 2024-07-02 4:58 pm Sale | 13D | TELA Bio Inc. TELA | ORBIMED ADVISORS LLC | 2,437,967 9.900% | -428,300 (-14.94%) | View |
| 2024-06-10 09:00 am Sale | 13G | TELA Bio Inc. TELA | First Light Asset Management LLC | 0 0.000% | -2,723,028 (Position Closed) | View |
| 2024-02-14 5:23 pm Purchase | 13G | TELA Bio Inc. TELA | First Light Asset Management LLC | 2,723,028 11.120% | 194,428 (+7.69%) | View |
| 2024-02-14 06:35 am Purchase | 13G | TELA Bio Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 4,110,709 16.790% | 5,000 (+0.12%) | View |
| 2024-02-07 6:55 pm Sale | 13G | TELA Bio Inc. TELA | HIRSCHMAN ORIN | 1,377,945 5.600% | -301,336 (-17.94%) | View |
| 2023-10-06 11:47 am Purchase | 13G | TELA Bio Inc. TELA | First Light Asset Management LLC | 2,528,600 10.330% | 2,528,600 (New Position) | View |
| 2023-04-21 5:03 pm Sale | 13D | TELA Bio Inc. TELA | ORBIMED ADVISORS LLC | 2,866,267 11.900% | -192,000 (-6.28%) | View |
| 2023-02-15 06:56 am Purchase | 13G | TELA Bio Inc. TELA | HIRSCHMAN ORIN | 1,679,281 8.700% | 161,289 (+10.63%) | View |
| 2023-02-14 10:10 am Sale | 13G | TELA Bio Inc. TELA | RTW INVESTMENTS LP | 390,364 2.000% | -1,009,322 (-72.11%) | View |
| 2022-08-23 5:56 pm Purchase | 13G | TELA Bio Inc. TELA | HIRSCHMAN ORIN | 1,517,992 7.900% | 1,517,992 (New Position) | View |
| 2022-08-22 3:19 pm Purchase | 13D | TELA Bio Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 4,105,709 21.430% | 500,000 (+13.87%) | View |
| 2022-08-19 4:17 pm Unchanged | 13D | TELA Bio Inc. TELA | ORBIMED ADVISORS LLC | 3,058,267 16.500% | 0 (Unchanged) | View |
| 2022-07-18 4:20 pm Purchase | 13D | TELA Bio Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 3,605,709 24.760% | 150,000 (+4.34%) | View |
| 2022-06-23 06:31 am Sale | 13G | TELA Bio Inc. TELA | Quaker BioVentures II LP | 18,096 0.120% | -1,751,100 (-98.98%) | View |